Berking Biotechnology is a company that was born in the south of Chile, in the city of Valdivia, surrounded by lush forests, rivers and of course, surrounded by the intense Valdivian rainforest. Founded in July 2017, we are born from the idea of creating new solutions to existing problems by exploiting innovative scAb technology to facilitate research.
We work with researchers from all over the world, including countries such as Germany, Australia, South Africa, Korea, among others, being able to accredit biotechnological research at an international level, in addition to having our own range of products and services.
Our current projects include the generation of scAbs for the cell signalling and cell cycle pathways, as well as affinity based reagents. In the next years, we will be working on having our own R&D department to apply scAbs on rare diseases and aquaculture.
Our team is made up of expert biochemists and biotechnologists, with years of experience in the research and development of innovative technologies.
Dr. Anne Berking
Anne is one of the founders of Berking Biotechnology. She studied Biology at the University of Konstanz where she also obtained her PhD in Cell Biology. After working as a Postdoc at the University of Dundee, she started her career in the pharmaceutical sector at ProPharma Group.
Dr. Alejandro Rojas
Alejandro is a co-founder of Berking Biotechnology. He studied Biotechnology at the University of Chile and earned his doctorate at the University of Konstanz. Before founding the Laboratory of Medical Biotechnology at the Austral University of Chile, he worked as a Postdoc at the University of Dundee and GlaxoSmithKline.
Sebastian studied Molecular Biotechnology at the University of Chile and holds a diploma in Project Management. He worked as an Investigator and Project Manager at Centrovet and Virbac and started his own R&D consulting firm Adatec.
Yorka studied Biochemistry at the Universidad Austral de Chile, and later obtained a Master’s degree at the same University. She has years of experience working as a researcher at the Biotechnology Laboratory of Universidad Austral of Chile. She is currently working as Production Manager at Berking Biotechnology.
Dr. Guillermo Valenzuela
Guillermo studied Biochemistry at the Universidad Austral de Chile, and obtained his PhD in Science at the same University. He has years of experience in antibody research and development, working as a researcher at the Medical Biotechnology Laboratory of the Universidad Austral de Chile.
Paulina is Audit accountant graduated from Universidad Austral de Chile. She obtained a Bachelor of Science of Management at the École Supérieure du Commerce in Montpellier, France. She currently works in the financial, administrative and accounting area of Berking Biotechnology.
Nano-SRS: Nanobodies para el tratamiento de SRS en salmones
Prv-free: tratamiento inmune pasivo contra prv basado en nanobodies para salmónidos de cultivo.